Robotic Urologic Surgery: A Technical Masterclass (2018)
Robotic Urologic Surgery: A Technical Masterclass provides a structured approach to advanced robotic surgery for conditions of the prostate, kidney, and bladder with an emphasis on radical prostatectomy and partial nephrectomy. This course will also focus on emerging technologies including genomic testing and advanced imaging. Experienced world-class faculty with more than a decade of experience with complex robotic surgery will provide you with instruction to refine your technique and achieve superior results.
The first day will focus on prostate surgery. Specific surgical techniques will be presented in a step-by-step operative outline. Issues such as optimizing outcomes of robotic radical prostatectomy, discussing complications, and tips and tricks of challenging cases. High Definition live transmission of robotic radical prostatectomy by Dr. Vipul Patel will include recent modifications in technique. The second day will be devoted to kidney surgery and bladder surgery. The course will include multiple video segments demonstrating tips and tricks, management of anatomic anomalies and challenging situations, with expert faculty to provide commentary and discussion. Audience participation will be encouraged to ensure one on one interaction. Panel discussions with expert faculty will address methods to recognize and address complications and problems for each of the surgical procedures.
At the conclusion of this course, learners will be able to:
- Examine and analyze the surgical techniques and methodology behind complex robotic urologic cancer surgeries such as prostatectomy, cystectomy and partial nephrectomy.
- Assess the key complications and outline the intra-operative and post-operative management related to robotic surgery procedures using video-based learning, surgical video and live surgery and expert panel discussion.
- Demonstrate current and upcoming protocols for regaining potency and continence following robotic prostatectomy and cystectomy.
- Provide a clinical update on treating, diagnosing, and managing complications of localized, regionally advanced, and metastatic urinary cancer.
- Provide a clinical update on emerging technologies in prostate cancer including MRI Fusion Biopsy, single port surgery, and genomic testing.
- Apply the surgical techniques and methodology behind complex robotic cancer surgeries including partial nephrectomy, robotic prostatectomy, and nephroureterectomy.
Melia Orlando Suite Hotel
225 Celebration Pl
Celebration, FL 34742
Please call the hotel at 1-407-964-7465 and reference the American Urological Association when making your reservation to receive the special group rate.
Online reservations cannot obtain the group rate.
To hold a reservation, a major credit card number must be provided.
$129 single/double occupancy. Please call 1-407-964-7465 and reference the American Urological Association when making your reservation to receive the special group rate.
Please note: To receive the discounted group rate, you must call the hotel directly and reference the AUA by Wednesday, October 10, 2018. Online codes are not available.
Cut-off Date: Wednesday, October 10, 2018. Once the AUA group block is full, which may be prior to the cut-off date, the AUA is unable to guarantee rooms at this rate or at this hotel.
Check-in: 4 p.m.
Check-out: 11 a.m.
Complimentary self-parking is available at the hotel.
Hertz is pleased to offer special discounted car rental rates to AUA course and meeting attendees. Make your reservation online or call 1-800-654-2240. Mention the AUA discount code CV# 04SG0003.
Vipul Patel, MD, FACS
Professor of Urology, University of Central Florida
Medical Director, Global Robotics Institute
Medical Director, Florida Hospital Cancer Institute Urologic Oncology Program
Sam Bhayani, MD
Robert Peter Carroll, MD, MPH
Rafael Ferreira Coelho, MD
Chief of Urology, Sao Paulo State Cancer Institute
University of Sao Paulo School of Medicine
Sao Paulo, Brazil
Matthew Randal Cooperberg, MD, MPH
John Warren Davis, MD
Associate Professor and Director Urosurgical Prost
MD Anderson Cancer Center ‐ Department of Urology
James Roscoe Porter, MD
Director, Robotic Surgery
Swedish Urology Group
Raj Som Pruthi, MD
Professor and Chair
University of North Carolina
Bernardo Maria Maria Rocco, MD
Joseph A. Smith, Jr., MD
Professor, Department of Urologic Surgery
Chandru P. Sundaram, MD
Professor and program Director
Director of Minima
Indiana University Department of Urology
Samir Taneja, MD
The James M. and Janet Riha Neissa Professor of Urologic Oncology
Professor of Urology and Radiology
Director, Division of Urologic Oncology
Co‐Director, Smilow Comprehensive Prostate Cancer Institute
Department of Urology, NYU Langone Medical Center
New York, NY
Raju Thomas, MD, FACS, FRCS, MHA
Professor and Chair
Tulane University School of Medicine
Department of Urology
New Orleans, LA
|Sam B. Bhayani, MD||Intuitive||Consultant or Advisor||Yes||02/11/2018|
|Robert Peter Carroll, MD, MPH||NIH||Scientific Study or Trial||Yes||01/19/2018|
|Department of Defense||Scientific Study or Trial||Yes||01/19/2018|
|AUA Update||Leadership Position||Yes||01/19/2018|
|Genomic Health||Scientific Study or Trial||No||01/19/2018|
|Rafael Ferreira Coelho, MD||Nothing to disclose|
|Matthew Randal Cooperberg, MD, MPH||Dendreon||Consultant or Advisor||Yes||04/03/2018|
|Myriad Genetics||Consultant or Advisor||Yes||04/03/2018|
|Astellas||Consultant or Advisor||Yes||04/03/2018|
|MDx Health||Consultant or Advisor||Yes||04/03/2018|
|GenomeDx||Meeting Participant or Lecturer||Yes||04/03/2018|
|John Warren Davis, MD||Genprobe||Scientific Study or Trial||No||04/02/2018|
|Janssen||Scientific Study or Trial||No||04/02/2018|
|GenomeDx||Scientific Study or Trial||Yes||04/02/2018|
|British Journal of Urology International||Health Publishing||Yes||04/02/2018|
|Intuitive||Consultant or Advisor||Yes||04/02/2018|
|Vipul Patel, MD||Surgical Specialties||Consultant or Advisor||Yes||04/03/2018|
|Mimedx||Consultant or Advisor||Yes||04/03/2018|
|GenomeDx||Consultant or Advisor||No||04/03/2018|
|Teleflex||Consultant or Advisor||Yes||04/03/2018|
|Titan||Consultant or Advisor||Yes||04/03/2018|
|Genomic Health||Consultant or Advisor||Yes||04/03/2018|
|James Roscoe Porter, MD||Intuitive Surgical||Meeting Participant or Lecturer||Yes||02/12/2018|
|CSATs||Consultant or Advisor||Yes||02/12/2018|
|Raj Som Pruthi, MD||MDxHealth||Consultant or Advisor||Yes||12/28/2017|
|Bernardo Maria Maria Rocco, MD||AB Medica||Other : surgical tutor for robotic surgery||Yes||04/04/2018|
|Joseph A. Smith, Jr., MD||Nothing to disclose|
|Chandru P. Sundaram, MD||Journal of Endourology and Videourology||Leadership Position||Yes||04/02/2018|
|Sonacare Inc.||Scientific Study or Trial||No||04/02/2018|
|OnTarget Inc||Scientific Study or Trial||No||04/02/2018|
|Society of Academic Urologists||Leadership Position||No||04/02/2018|
|Endourological Society||Leadership Position||No||04/02/2018|
|Samir Taneja, MD||Elsevier||Health Publishing||Yes||01/31/2018|
|Insightec||Consultant or Advisor||Yes||01/31/2018|
|Mdx Health||Scientific Study or Trial||Yes||01/31/2018|
|Biobot||Consultant or Advisor||No||01/31/2018|
|Raju Thomas, MD, FACS, FRCS, MHA||Gulf South Lithotripsy||Leadership Position, Investment Interest||Yes||01/05/2018|
|AUA Annual CME Courses||Meeting Participant or Lecturer||Yes||01/05/2018|
|Journal of Endourology||Health Publishing, Consultant or Advisor||No||01/05/2018|
|Journal of Urology||Health Publishing, Meeting Participant or Lecturer||No||01/05/2018|
|Urology Gold Journal||Other : Review articles||No||01/05/2018|
|Olympus||Other : Speaker||Yes||01/05/2018|
|Education Council Disclosures|
|Michael R. Abern, MD||Department of Defense Prostate Cancer Research Program||Scientific Study or Trial||Yes||4/2/2018|
|American Urological Association Office of Education||Consultant or Advisor||Yes||4/2/2018|
|Department of Defense Prostate Cancer Research Program||Consultant or Advisor||Yes||4/2/2018|
|Sero Andonian, MD||Lumenis||Meeting Participant or Lecturer, Scientific Study or Trial||Yes||4/2/2018|
|Timothy Charles Brand, MD||Nothing to disclose||4/2/2018|
|Anthony A. Caldamone, MD||Nothing to disclose||4/2/2018|
|Matthew S. Christman, MD||Nothing to disclose||3/3/2018|
|John D. Denstedt, MD||Cook Urology||Owner, Product Development||Yes||4/3/2018|
|Endourological Society||Leadership Position||Yes||4/3/2018|
|Endourological Society||Health Publishing||Yes||4/3/2018|
|Jody Donaldson||Nothing to disclose||4/9/2018|
|Shelby Englert||Nothing to disclose||4/9/2018|
|Allen Gao, MD, PhD||Pandomedx||Leadership Position, Owner, Product Development||Yes||4/9/2018|
|Matthew Thomas Gettman, MD||COVR Medical||Consultant or Advisor||Yes||2/27/2018|
|Intuitive Surgical||Consultant or Advisor||Yes||2/27/2018|
|Exact Sciences||Scientific Study or Trial||Yes||2/27/2018|
|Howard B. Goldman, MD||allergan||Consultant or Advisor||Yes||4/2/2018|
|Medtronic||Consultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial||Yes||4/2/2018|
|Cook||Scientific Study or Trial||No||4/2/2018|
|Nuvectra||Consultant or Advisor||Yes||4/2/2018|
|Axonics||Consultant or Advisor||Yes||4/2/2018|
|NewUro||Consultant or Advisor||Yes||4/2/2018|
|Galvani||Consultant or Advisor||Yes||4/2/2018|
|bioness||Scientific Study or Trial||No||4/2/2018|
|William C. Huang, MD||Photocure||Scientific Study or Trial||Yes||2/22/2018|
|Karl Storz||Scientific Study or Trial||Yes||2/22/2018|
|William C. Hulbert, Jr., MD||Nothing to disclose||4/5/2018|
|Brant Inman, MD, MS, FRCSC||Dendreon||Scientific Study or Trial||No||4/3/2018|
|Genentech Inc||Scientific Study or Trial||No||4/3/2018|
|Combat Medical||Consultant or Advisor, Scientific Study or Trial||Yes||4/3/2018|
|FKD Therapies||Scientific Study or Trial||No||4/3/2018|
|Nucleix||Scientific Study or Trial||Yes||4/3/2018|
|Urogen||Scientific Study or Trial||Yes||4/3/2018|
|Mark L. Jordan MD,FACS||Nothing to disclose||3/8/2018|
|Martin A. Koyle, MD||Nothing to disclose||4/3/2018|
|Yair Lotan, MD||abbott||Scientific Study or Trial||No||4/2/2018|
|Cepheid||Consultant or Advisor, Scientific Study or Trial||No||4/2/2018|
|Pacific Edge||Scientific Study or Trial||No||4/2/2018|
|FKD||Scientific Study or Trial||No||4/2/2018|
|MDxHealth||Consultant or Advisor, Scientific Study or Trial||Yes||4/2/2018|
|biocancell||Scientific Study or Trial||No||4/2/2018|
|GenomeDx Biosciences Inc||Scientific Study or Trial||No||4/2/2018|
|photocure||Consultant or Advisor, Scientific Study or Trial||No||4/2/2018|
|Nicole Lara Miller, MD||Boston Scientific Corporation||Consultant or Advisor, Meeting Participant or Lecturer||Yes||4/3/2018|
|Practical Reviews In Urology||Health Publishing||Yes||4/3/2018|
|Manoj Monga, MD, FACS||Fortec||Other||Yes||4/3/2018|
|Ajay Kumar Nangia, MBBS, FACS||AUA News||Leadership Position, Health Publishing||Yes||4/2/2018|
|NIH CCN Trial||Scientific Study or Trial||Yes||4/2/2018|
|Urology Care Foundation||Leadership Position||No||4/2/2018|
|AUA Health Policy Council||Leadership Position||No||4/2/2018|
|South Central AUA||Leadership Position||No||4/2/2018|
|Curtis Nickel, MD||Farr Laboratories||Consultant or Advisor||Yes||4/4/2018|
|Aquinox||Scientific Study or Trial||No||4/4/2018|
|PureTech Health||Consultant or Advisor||Yes||4/4/2018|
|NIH||Scientific Study or Trial||Yes||4/4/2018|
|Canadian Institute of Health Research||Scientific Study or Trial||Yes||4/4/2018|
|Interface Biologics||Consultant or Advisor||Yes||4/4/2018|
|Alvio Therapeutics||Consultant or Advisor||Yes||4/4/2018|
|Seikagaku Corporation||Consultant or Advisor||Yes||4/4/2018|
|Medifocus||Consultant or Advisor||Yes||4/4/2018|
|RedLeaf Medical||Consultant or Advisor||Yes||4/4/2018|
|Victor William Nitti, MD||Astellas||Health Publishing, Scientific Study or Trial||No||4/9/2018|
|Allergan||Health Publishing, Scientific Study or Trial||No||4/9/2018|
|Serenity Pharmeuticals||Investment Interest||Yes||4/9/2018|
|Medtronic||Scientific Study or Trial||No||4/9/2018|
|Christopher Porter, MD||Nothing to disclose||1/23/2018|
|Ganesh V. Raj, MD, PhD||Ptares||Owner, Product Development||Yes||1/31/2018|
|C-diagnostics corp||Consultant or Advisor, Investment Interest||Yes||1/31/2018|
|amgen||Meeting Participant or Lecturer||Yes||1/31/2018|
|Johnson and Johnson||Consultant or Advisor, Owner, Product Development||Yes||1/31/2018|
|Astellas||Meeting Participant or Lecturer||Yes||1/31/2018|
|ASTELLAS||Consultant or Advisor, Meeting Participant or Lecturer||Yes||1/31/2018|
|Janssen||Owner, Product Development||Yes||1/31/2018|
|BAYER||Consultant or Advisor, Meeting Participant or Lecturer||Yes||1/31/2018|
|SANOFI||Consultant or Advisor, Meeting Participant or Lecturer||Yes||1/31/2018|
|GaudiumRx||Leadership Position, Investment Interest, Owner, Product Development||Yes||1/31/2018|
|Medivation||Consultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial||Yes||1/31/2018|
|EtiraRx||Leadership Position, Investment Interest, Owner, Product Development||Yes||1/31/2018|
|Jay D. Raman, MD||American Kidney Stone Management||Investment Interest||Yes||4/9/2018|
|MDx Health||Scientific Study or Trial||No||4/9/2018|
|Lee Richstone, MD||Nothing to disclose||1/5/2018|
|Heather Schultz||SUNA||Meeting Participant or Lecturer||Yes||4/4/2018|
|Karl-Dietrich Sievert, MD, PhD||Medtronics||Meeting Participant or Lecturer, Scientific Study or Trial||Yes||4/10/2018|
|Allergen||Consultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial||Yes||4/10/2018|
|Neotract||Meeting Participant or Lecturer||Yes||4/10/2018|
|Stimguard||Meeting Participant or Lecturer, Scientific Study or Trial||Yes||4/10/2018|
|Joseph A. Smith Jr., MD||Nothing to disclose||2/15/2018|
|Ryan Patrick Terlecki, MD, FACS||American Medical Systems||Consultant or Advisor, Other||Yes||4/7/2018|
|Boston Scientific||Consultant or Advisor||Yes||4/7/2018|
|MicroGen Dx||Consultant or Advisor||Yes||4/7/2018|
|U.S. Department of Defense||Scientific Study or Trial||Yes||4/7/2018|
|Edouard John Trabulsi, MD, FACS||GenomeDx||Consultant or Advisor||Yes||4/2/2018|
|Janssen||Consultant or Advisor, Meeting Participant or Lecturer||Yes||4/2/2018|
|Pfizer||Consultant or Advisor, Meeting Participant or Lecturer||Yes||4/2/2018|
|Merck||Meeting Participant or Lecturer||Yes||4/2/2018|
The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Urological Association designates this live activity for a maximum of 14 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.
Evidence Based Content
It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.
AUA Disclosure Policy
All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) participating in an educational activity provided by the AUA are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual's relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.
Resolution of Identified Conflict of Interest
All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:
- Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or Education Content Review Committee or its subgroup.
- Limit content to evidence with no recommendations
- Introduction of a debate format with an unbiased moderator (point-counterpoint)
- Inclusion of moderated panel discussion
- Publication of a parallel or rebuttal article for an article that is felt to be biased
- Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
- Divestiture of the relationship by faculty
Off-label or Unapproved Use of Drugs or Devices
It is the policy of the AUA to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.
Attendee Information & Policies
The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the American Urological Association (AUA).
Consent to Use of Photographic Images
Registration and attendance at or participation in AUA meetings and other activities constitutes an agreement by the registrant to AUA's use and distribution (both now and in the future) of the registrant or attendee's image or voice in photographs, videotapes, electronic reproductions, and audiotapes of such events and activities.
Audio, Video, Photographic Equipment
The use of audio, video and other photographic recording equipment by attendees is prohibited inside AUA meeting rooms.
Reproduction of written materials developed for this AUA course is prohibited without the written permission from individual authors and the AUA.
Special Assistance/Dietary Needs
The AUA complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the registration desk.
- 14.00 AMA PRA Category 1 Credit™
- 14.00 Non-Physician Participation